FINANCIAL CONSULATE, INC

Position in ABBV — AbbVie Inc.

CIK 1624510 HUNT VALLEY, MD

Position in ABBV

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$796,943

+$129,467 QoQ

Shares Held

3,167

+3.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

#2,760

of 4,153 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 79% Shared 0% None 21%

Healthcare · as of Jun 30, 2026

FINANCIAL CONSULATE, INC holds $4,839,565 across 15 Drug Manufacturers - General names. ABBV ranks #4 (16.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,232	$1,477,697
2	MRK	Merck & Co., Inc.	7,599	$976,471
3	JNJ	Johnson & Johnson	3,667	$931,307
4	ABBV	AbbVie Inc. This page	3,167	$796,943
5	AZN	Astrazeneca PLC	870	$164,969
6	AMGN	Amgen Inc	445	$161,143
7	BMY	Bristol Myers Squibb Co	1,572	$90,578
8	NVS	Novartis AG	515	$80,710

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$796,943	3,167	+3.2%	Shares	Sole	2026-07-23
2026-03-31	$667,476	3,069	+2.0%	Shares	Sole	2026-04-21
2025-12-31	$687,297	3,008	-4.8%	Shares	Sole	2026-01-22
2025-09-30	$731,434	3,159	+25.7%	Shares	Sole	2025-10-21
2023-03-31	$400,656	2,514	+1.4%	Shares	Other	2023-04-17
2022-12-31	$400,631	2,479	-28.7%	Shares	Other	2023-01-11
2022-09-30	$466,782	3,478	+0.1%	Shares	Other	2022-10-20
2022-06-30	$532,384	3,476	+0.0%	Shares	Other	2022-07-19
2022-03-31	$563,332	3,475	+5.5%	Shares	Other	2022-04-28
2021-12-31	$446,007	3,294	+0.0%	Shares	Sole	2022-02-07
2021-09-30	$355,215	3,293	+43.7%	Shares	Other	2021-10-19
2021-06-30	$258,058	2,291	+1.1%	Shares	Other	2021-07-22
2021-03-31	$245,118	2,265	+0.1%	Shares	Other	2021-04-19
2020-12-31	$242,480	2,263	—	Shares	Other	2021-01-29
No filing history on record for this holder in this stock.